Patented New Product for Contemporaneous Validation of Clinical Practice. Now More Important than Ever, for Accurate, Real-time Data, and Saving Clinicians’ Time

https://clearprotocol.com/

Hello. Thank you, SoCalBio for the opportunity to list on your Project Hub.
(short description enclosed, below the signature)

Regarding COVID-19, please consider the following. What would be as important as a rapid test, or a vaccine? Having a practical way to validate that they are being administered in an approved manner and automatically record who received them. This is what our product Clear Protocol®, does. Also, it will potentially save healthcare workers hours a day in data entry tasks.

Brief intro PDF whitepaper can be found at this link:
https://drive.google.com/file/d/1SUSsLA9FdPdmbktnG1gJTpTDnWHPG1nq/view?usp=sharing

Feel free to call if any questions. Thank you.
Regards,
Ernest M. Kestone
Clear Protocol, Inc.
(626) 888-2378 voice/text anytime during business hours, Pacific Time.
ernest@ClearProtocol.com

Brief Product Description:
Clear Protocol® is an electronic tool for doctors and nurses to validate and log clinical procedures while helping eliminate the documentation burden.

Elevator Pitch
Most procedures in a hospital are at the patient’s bedside, however, in this setting, none of the existing IT conforms with clinicians’ needs and required standards. As a result, clinicians may spend more time on computers than seeing patients. Clear Protocol® is a practical tool for doctors that can potentially save them hours a day, as well as meeting standards. Our solution promises a high investment return and social value: Patented, Healthcare Business to Business, Software as a Service.

Unique benefits, how it solves an unmet need
Clear Protocol® automates clinical documentation, a process that right now has to be done manually, on the doctor’s time. With Clear Protocol® documentation will be completed contemporaneously while rounding or treating a patient.

Detailed Company Description
a) The industry is U.S. healthcare: total $3.5 trillion annual revenue. The target market is the appx. 5% spent on IT, $175 billion. The near-term addressable market is in our home-base in Southern California, the largest concentration of urban hospitals. Easier access for marketing, a large pool of experienced healthcare employees, and many universities with graduates in related fields.
b) Outlook “Hospitals must adapt to value-based, evidence-based, and personalized medicine, by upgrading their IT” (HIMSS 2019 Healthcare Trends Forecast). The need to limit healthcare waste and bring costs in line with the rest of the U.S. economy creates the demand for Clear Protocol®.
c) Demographics indicates that U.S. healthcare expenditures will continue to rise along with our business. Our initial patent is in effect until 2035, and by then we will have additional patents, built-up capital reserves, irreplaceable proprietary knowledge, a uniquely skilled workforce, and goodwill with institutional customers.
d) Products and services

Clear Protocol®
-An enterprise-level hardware and software system that uses electronic wearables
-Will be used 24/7 by every nurse and doctor working at a hospital, to validate treatment protocols contemporaneously
-Hands-free, voice-operated. Users select a procedure on the Clear Protocol® voice-activated platform, and then confirm the completed steps in real time
-Completed protocols are logged automatically to the patient’s records/EHR and/or the billing system, as desired
-Is “hardware-agnostic”. Based on user preference, electronic wearables will be programmed with our proprietary software
-Can be “deviceless” (an over-the-ear microphone/speaker), or it can function via smart glasses, a customized body cam, a wristband, or configured as a “badge-style” device worn on the lapel.
Unique benefits, how it solves an unmet need Clear Protocol® automates clinical documentation, a process that right now has to be done manually, on the doctor’s time. With Clear Protocol® documentation will be completed contemporaneously while rounding or treating a patient.
Competitive advantage
-The only computerized validation system we know of that meets the Agency for Healthcare Research and Quality’s “Five Rights of CDS”
-Utility Patent issued June, 2019, US 10,318,928B1; other patents pending
-Flexible workflows customized to the individual user
-The user initiates the validation, so the user is in control of which items will be logged
-Potentially saves clinicians hours per day in documentation
-Plug and play upgrades whenever new clinical guidelines are adopted
-Interoperable with the major EMR systems
-Potential to add a module for voice-to-text comments to the patient’s EMR, so nearly all charting/documentation can be completed contemporaneously

How we will make money
Software-as-a-Service (SAAS). Revenue will come from initial setup and training fees, and “per bed” or “per user” site license subscriptions.

Brief intro PDF whitepaper can be found at this link:
https://drive.google.com/file/d/1SUSsLA9FdPdmbktnG1gJTpTDnWHPG1nq/view?usp=sharing
____________________________________